How to Obtain a CLIA Certificate of Waiver
START POINT-OF-CARE TESTING
Test For COVID-19 At Your Pharmacy, Workplace or Facility
As more opportunities arise for pharmacies to provide point-of-care testing, it’s increasingly important to be prepared to provide these tests. A CLIA Certificate of Waiver allows your pharmacy to perform point-of-care tests that have a waived degree of complexity as assigned by the U.S. Food and Drug Administration according to 42 CFR 493.15(c). This now includes testing for SARS-CoV-2, the virus that causes COVID-19.
This page will guide you through completing a CLIA application and provide state-specific submission instructions.
Billing Codes for COVID-19 Rapid Antigen Tests
U0002: 2019-nCoV coronavirus, SARS-CoV-2 /2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC
Specimen Collection Code
G2023: Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), any specimen source
CPT Antigen Code
CPT code 87426 for infectious agent antigen detection by immunoassay technique of SARS-CoV and/or SARS-CoV-2 is effective and must be used for dates of service as of June 25, 2020, and after.